What is Merrimack Pharmaceuticals Operating Cash Flow per Share?
Merrimack Pharmaceuticals's operating cash flow per share for the
three
months ended in Dec. 2023 was $-0.02.
Merrimack Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.11.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 32.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 58.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 43.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Merrimack Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:
MACK'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -41.8 Med: 25.5 Max: 85.2
Current: 32.6
During the past 13 years, Merrimack Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 85.20% per year. The lowest was -41.80% per year. And the median was 25.50% per year.
MACK's 3-Year OCF Growth Rate is ranked better than 80.84% of 1242
companies
in the Biotechnology industry
Industry Median: 3.6
vs MACK: 32.60
Merrimack Pharmaceuticals Operating Cash Flow per Share Historical Data
The historical data trend for Merrimack Pharmaceuticals's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merrimack Pharmaceuticals Operating Cash Flow per Share Chart
Competitive Comparison of Merrimack Pharmaceuticals's Operating Cash Flow per Share
For the Biotechnology subindustry, Merrimack Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merrimack Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Merrimack Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Merrimack Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Merrimack Pharmaceuticals Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Merrimack Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merrimack Pharmaceuticals Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Merrimack Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Merrimack Pharmaceuticals (Merrimack Pharmaceuticals) Business Description
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MACK has been successfully added to your 